The global gamma probe devices market is set for a transformative decade, with new research by Future Market Insights (FMI) forecasting substantial growth. Valued at USD 86.9 million in 2023, the market is projected to expand at a CAGR of 9.8%, reaching an impressive USD 244.3 million by 2033.
A key driver of this growth is the increasing preference for trolley-mounted gamma probe devices, which are expected to capture 38.7% of the market share in 2023. Their versatility and efficiency across a range of medical applications have positioned them as indispensable tools in surgical settings.
Sentinel Lymph Node Biopsies Propel Demand
The market’s expansion is strongly linked to their critical role in sentinel lymph node biopsies, widely used for staging melanoma and breast cancer. Increasing adoption in procedures for other cancer types further broadens their applications. Additionally, reports from the International Atomic Energy Agency (IAEA) highlight a surge in parathyroid detection using intraoperative gamma probes, further emphasizing their relevance.
With breast cancer remaining the most prevalent cancer among women worldwide, as noted by the World Cancer Research Fund International, the demand for gamma probe devices is expected to rise significantly. Over 2 million new cases of breast cancer are diagnosed globally each year, creating an urgent need for advanced diagnostic and surgical tools.
Innovation Drives Market Evolution
Innovations such as click-on gamma probes and the DROP-IN gamma probe concept are transforming surgical practices. These advancements enable seamless integration with robotic instruments, offering surgeons enhanced control and autonomy during operations.
Challenges and Opportunities
Despite promising growth, the market faces challenges, particularly the high installation and maintenance costs of gamma probe devices. However, ongoing technological advancements and efforts to develop cost-effective solutions are expected to address these barriers.
Comprehensive Market Insights
FMI’s report, titled “Gamma Probe Devices Market,” offers an in-depth analysis of the macro and microeconomic factors shaping the market. It provides actionable insights to help stakeholders navigate this rapidly evolving sector.
As technological innovations continue to reshape the healthcare landscape, the gamma probe devices market stands at the forefront of medical advancement, offering hope and enhanced surgical outcomes for millions of patients worldwide.
“We’re witnessing a dynamic shift towards trolley-mounted devices, driven by their growing demand,” notes an FMI market analyst. “These devices offer unmatched versatility and efficiency, making them the preferred choice for various surgical procedures.”
Key Takeaways from Gamma Probe Devices Market:
- North America holds a significant market share with the US being subject to concentration on improvising on flexibility, throughput, and productivity. Nuclear therapies’ frequency is increasing due to remarkable investments in research on this count.
- Europe stands second with Germany leading from the front. This could be credited to well-established players being present over here along with rising spending on healthcare.
- The Asia-Pacific is expected to grow at a rapid pace in the gamma probe devices market in the forecast period with China dominating the scene. This could be reasoned with growing frequency of chronic ailments.
Increased Market Demand: Get In-Depth Analysis and Insights with Our Complete Report!
Competitive Devices:
- Southern Scientific, in October 2021, entered into collaboration with Helgeson. The latter comes across as a producer of various detectors, equipment, and area monitors with more than 3 decades of experience in nuclear therapy.
- KUBTEC, in May 2022, did acquire Wprobe Technology from ‘Oncovision’s firm’. The technology is looked upon as a gold standard in the radio-guided surgery and does involve a spectrum of wireless gamma probes to identify sentinel lymph node.
- Lightpoint Medical, in February 2022, did report that Dr. Doug Adams (one of the specialists in robotic thoracic surgery at Bethesda North Hospital (part of TriHealth, Ohio)) performed the first of its kind lung procedure with SENSEI (new miniature robotic gamma probe).
What does the Report probe?
- The research study is based on modality (handheld device, benchtop device, and trolley mounted device), by application (thyroid uptake and sentinel lymph node uptake (breast cancer, melanoma, colon cancer, NSCLC, renal cancer, and others), and by end-user (hospitals, ASCs (Ambulatory Surgical Centers), and specialty centers and clinics).
- With growing awareness regarding advantages of gamma radiation over traditional detection methods such as X-Rays, the global gamma probe devices market is expected to stand in a good stead in the near future.
Key Companies Covered:
- Biodex Medical Systems, Inc.
- CAPINTEC, INC.
- Crystal Photonics GmBH
- Devicor Medical Products, Inc (Mammotome)
- Dilon Technologies, Inc
- Gamma Medical Technology
- Intramedical Imaging
- Intramedical Imaging
- KUB Technologies
- L’ACN – l’Accessorio Nucleare
- Mammotome
- NUCLEAR MEDSYSTEMS
- Oncovision
- Southern Scientific Ltd.
Key Market Segments Covered in Gamma Probe Devices Industry Research:
Modality:
- Hand Held Device
- Benchtop Device
- Trolley Mounted Device
Application:
- Thyroid Uptake
- Sentinel Lymph Node Uptake
- Breast Cancer
- Melanoma
- Colon Cancer
- NSCLC
- Renal Cancer
- Others
End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Centers and Clinics
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube